查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1992657

持續性周邊神經阻斷導管市場：按類型、導引技術、最終用戶和應用分類－2026-2032年全球預測

Continuous Peripheral Nerve Block Catheter Market by Type, Guidance Technology, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，持續性周邊神經阻斷導管市場價值為 4.2618 億美元，預計到 2026 年將成長至 4.5017 億美元，複合年成長率為 5.88%，到 2032 年將達到 6.3601 億美元。

主要市場統計數據
基準年 2025 4.2618億美元
預計年份：2026年 4.5017億美元
預測年份 2032 6.3601億美元
複合年成長率 (%) 5.88%

權威概述了影響將連續性周邊神經阻斷導管引入現代醫療路徑的臨床、操作和採購因素的演變。

持續性周邊神經阻斷導管已成為術前和術後疼痛管理的核心，它能提供標靶鎮痛，減少全身性鴉片類藥物依賴，並促進患者康復。近年來，臨床醫生和採購團隊都對導管的設計、與引導技術的兼容性以及與多方面鎮痛通訊協定的整合便捷性等設備特性進行了深入研究。這些因素促使醫療機構在評估和實施持續性神經阻斷方案時發生了轉變，關注點從單一操作的效用轉向更廣泛的圍手術全期護理路徑，強調縮短住院時間和改善功能恢復。

對臨床重點、影像引導技術的進步以及醫療保健服務的變化如何匯聚，從而重新定義設備開發和部署的動態進行全面評估。

持續性周邊神經阻斷導管的市場格局正在經歷變革性變化，其促進因素包括臨床需求、技術融合以及醫療服務模式的轉變。臨床上，減少鴉片類藥物使用和加速復健通訊協定的策略正顯著增加，這使得可靠的局部麻醉技術變得尤為重要。這種臨床需求促使人們需要能夠提供可預測鎮痛效果，並在適當情況下支持早期物理治療和當日出院的器械。

對 2025 年價格調整對營運和採購的影響進行分析概述，以及供應鏈調整如何重塑商業策略。

2025年關稅政策的實施為醫療設備產業的採購、供應鏈管理和商業策略帶來了新的複雜性。關稅調整將影響製造、分銷和採購管道的成本結構，要求相關人員重新評估籌資策略和利潤率預期。對於依賴跨境供應鏈的製造商而言，這些變化促使他們審查供應商合約、在地採購，並探索建立庫存緩衝，以降低進口關稅波動帶來的風險並增強抵禦風險的能力。

綜合細分分析，解釋導管類型、影像和引導方法、臨床環境和手術應用如何共同影響採購和實施決策。

細分市場分析揭示了設備選擇和臨床部署如何因產品類型、引導技術、終端用戶環境和應用而異，每種情況都形成了其獨特的部署路徑。在按導管類型區分設備時，重點在於預期手術以及臨床醫生在非刺激性導管（便於插入）和刺激性導管（可在放置過程中提供神經定位反饋）之間的偏好。這種差異會影響訓練要求和手術通訊協定，因為在臨床實務中採用電刺激確認神經接近性的方法時，刺激性導管可能會更受歡迎。

本文闡述了美洲、歐洲、中東和非洲以及亞太地區的基礎設施、報銷制度和臨床實踐如何影響設備部署和商業化策略的細微區域差異。

區域動態，受醫療基礎設施、報銷系統和臨床實踐模式差異的影響，對醫療設備的選擇、臨床培訓模式和分銷策略產生顯著影響。在美洲，臨床上對加速復健、整形外科病例和產科服務的重視，推動了對支持早期復健和高安全性醫療設備的需求。在都市區三級醫療機構中，先進影像技術和跨學科協作受到重視，而門診機構則優先考慮能夠最大限度縮短手術時間並實現當日出院的醫療設備。

對產品創新、臨床醫生教育和服務模式如何整合以建立競爭優勢並影響局部麻醉領域的採購選擇進行策略性評估。

持續性周邊神經阻斷導管市場的競爭格局主要集中在產品創新、臨床支援服務以及在真實臨床環境中展現穩定性能的能力。領先的製造商透過導管材料和固定系統來降低導管脫落和感染的風險，並透過簡化無菌操作和超音波整合的配件包來脫穎而出。同樣重要的是培訓項目、模擬工具和臨床夥伴關係，這些都能透過提高臨床醫師的信心和操作一致性來加速產品的普及應用。

為製造商和醫療保健領導者提供實用建議，以使其產品開發、臨床醫生培訓和供應策略與臨床和營運重點保持一致。

產業領導者可以透過調整研發重點與終端用戶工作流程，並加強臨床支援體系，採取果斷行動，確保抓住臨床和商業性機會。他們可以透過優先提升導管功能，改善超音波影像視覺化、確保導管牢固固定並控制感染，來解決臨床醫生最常提及的實際挑戰。同時，投資擴充性的培訓項目和模擬工具，可以降低技能差異，加速技術應用，尤其是在醫院和門診中心等對操作人員一致性要求極高的場所。

高度透明的調查方法解釋瞭如何將與臨床醫生的初步訪談、臨床指南的整合以及產品比較分析相結合，從而得出可操作的見解。

本研究整合了同儕審查的臨床文獻、操作指南以及對麻醉醫師、手術全期護理師和採購負責人的初步定性訪談，旨在全面了解推動醫療器材應用的因素及其障礙。調查方法強調臨床實務洞察、產品功能評估和分銷管道分析之間的交叉檢驗，以確保結論既反映實證醫學，又符合日常營運的實際情況。

簡潔而前瞻性的結論，整合了臨床重點、操作實際情況和協作策略，以支持有效引入持續性周邊神經阻斷導管。

總之，持續性周邊神經阻斷導管在現代疼痛管理策略中發揮著至關重要的作用，其應用受到多種因素的共同影響：臨床需求、影像技術的進步以及不斷發展的醫療服務模式。該裝置的特性——與超音波的整合、牢固的固定以及可在門診進行管理——始終與門診手術中心、醫院和專科診所等各相關人員的優先事項相契合。同時，持續投入臨床醫生培訓和實證醫學研究對於維持其應用和提高操作規範性仍然至關重要。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：持續性周邊神經阻斷導管市場：依類型分類

  • 非刺激性導管
  • 刺激導管

第9章：依誘導技術分類的連續性周邊神經阻斷導管市場

  • 盲法
  • 神經刺激設備引導法
  • 超音波引導法

第10章：持續性周邊神經阻斷導管市場：依最終用戶分類

  • 門診手術中心
  • 醫院
  • 專科診所

第11章：持續性周邊神經阻斷導管市場：依應用領域分類

  • 產科鎮痛
    • 剖腹產
    • 分娩疼痛管理
  • 整形外科手術
    • 全髖關節置換術
    • 人工膝關節關節重建手術
    • 肩關節手術
  • 術後疼痛管理

第12章：連續性周邊神經阻斷導管市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：持續性周邊神經阻斷導管市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：持續性周邊神經阻斷導管市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國持續性周邊神經阻斷導管市場

第16章：中國周邊神經阻斷導管市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Avanos Medical, Inc.
  • B. Braun Melsungen AG
  • Dyna Medical Corporation
  • Epimed International Inc.
  • ICU Medical, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medline Industries, LP
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Owens & Minor, Inc.
  • PAJUNK GmbH Medizintechnologie
  • Poly Medicure Ltd.
  • Shunmei
  • Teleflex Incorporated
  • Vygon SA
Product Code: MRR-976C0ED91CFF

The Continuous Peripheral Nerve Block Catheter Market was valued at USD 426.18 million in 2025 and is projected to grow to USD 450.17 million in 2026, with a CAGR of 5.88%, reaching USD 636.01 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 426.18 million
Estimated Year [2026] USD 450.17 million
Forecast Year [2032] USD 636.01 million
CAGR (%) 5.88%

An authoritative introduction describing the evolving clinical, operational, and procurement drivers shaping continuous peripheral nerve block catheter adoption in modern care pathways

Continuous peripheral nerve block catheters have become a focal point in perioperative pain management, offering targeted analgesia that reduces systemic opioid reliance and enhances patient recovery. Over recent years, clinicians and procurement teams alike have scrutinized device characteristics such as catheter design, guidance technology compatibility, and ease of integration into multimodal analgesia protocols. These factors have driven an evolution in how healthcare organizations evaluate and adopt continuous nerve block solutions, with attention shifting from single-procedure utility toward broader perioperative pathways that emphasize reduced length of stay and improved functional recovery.

In parallel, clinical practice has increasingly favored technologies that align with enhanced recovery after surgery principles and ambulatory surgical care models. This trend has raised new expectations for device performance, including consistent block efficacy, secure fixation methods that permit early mobilization, and user interfaces that minimize procedure time. As a result, manufacturers and clinical leaders are forging closer collaborations to refine training, standardize protocols, and validate real-world outcomes, creating an environment where technological innovation and clinical evidence jointly influence purchasing and adoption decisions.

Consequently, stakeholders require clear, evidence-driven intelligence that synthesizes device design considerations, guidance technology implications, and end-user perspectives to inform procurement, clinician education, and value-based purchasing strategies. This report seeks to deliver that actionable intelligence by examining market dynamics, clinical adoption patterns, and practical recommendations for integrating continuous peripheral nerve block catheters into contemporary care pathways.

A comprehensive assessment of how clinical priorities, imaging guidance advances, and care delivery changes are converging to redefine device development and adoption dynamics

The landscape for continuous peripheral nerve block catheters is undergoing transformative shifts driven by clinical priorities, technology convergence, and changes in care delivery. Clinically, there is a pronounced move toward opioid-sparing strategies and enhanced recovery protocols, which elevates the importance of reliable regional anesthesia techniques. This clinical imperative has amplified demand for devices that deliver predictable analgesia while enabling early physiotherapy and same-day discharge where appropriate.

Technologically, the convergence of imaging guidance and catheter design is reshaping procedural workflows. Ultrasound guidance has emerged as a preferred modality in many settings because it improves visualization of nerve structures and local anesthetic spread, thereby enhancing block accuracy and safety. Simultaneously, manufacturers are optimizing catheter materials and fixation systems to reduce dislodgement and infection risk, which addresses key practical barriers encountered in ambulatory and inpatient environments. These technological advancements are complemented by improved training tools and simulation-based education that accelerate clinician competency and adoption.

Operational shifts in healthcare delivery also influence the trajectory of adoption. The growth of ambulatory surgical centers and shared-care models places a premium on devices that support streamlined procedures and consistent outcomes across disparate settings. In addition, evolving reimbursement frameworks and quality metrics emphasize patient-reported outcomes and reductions in opioid-related adverse events, creating incentives for hospitals and clinics to prioritize regional anesthesia solutions. Taken together, these clinical, technological, and operational forces are redirecting development priorities and commercial strategies across the value chain.

An analytical overview of the operational and procurement implications stemming from 2025 tariff changes and how supply chain adjustments are reshaping commercial strategies

The introduction of tariff policies in 2025 has introduced a new layer of complexity for procurement, supply chain management, and commercial strategy within the medical device sector. Tariff adjustments influence cost structures across manufacturing, distribution, and procurement channels, requiring stakeholders to reassess sourcing strategies and margin expectations. For manufacturers that rely on cross-border supply chains, these changes have triggered a review of supplier contracts, component localization, and inventory buffers to mitigate exposure to variable import duties and broaden resilience.

Hospitals and ambulatory centers respond to altered cost dynamics by tightening procurement specifications, extending tender cycles, and prioritizing devices that demonstrate not only clinical value but also predictable total cost of ownership. In some cases, purchasers explore alternative supplier relationships or consolidated purchasing agreements to offset additional tariff-induced costs. Meanwhile, smaller specialty clinics may face greater sensitivity to price changes, prompting clinicians to evaluate procedural workflows and device utilization to preserve access to regional anesthesia techniques without eroding clinical quality.

In response, manufacturers and distributors are exploring adaptive strategies such as nearshoring select production, redesigning packaging to reduce tariff exposure, and offering bundled service models that emphasize training, warranty, and consumable management. These approaches aim to preserve competitiveness while maintaining the clinical performance and support services that clinicians expect. The net effect of tariff changes is therefore not only financial but operational, compelling stakeholders to pursue pragmatic adjustments that sustain clinical access and long-term supplier partnerships.

An integrated segmentation analysis explaining how catheter type, imaging and guidance methods, clinical setting, and procedural application jointly determine procurement and adoption decisions

Insight into segmentation reveals how device selection and clinical deployment vary across product type, guidance technology, end-user setting, and application, each shaping distinct adoption pathways. When devices are differentiated by catheter type, considerations center on the intended procedural use and clinician preference for either nonstimulating catheters that simplify insertion or stimulating catheters that provide nerve localization feedback during placement. This distinction influences training requirements and procedural protocols because stimulating catheters may be favored in settings where electrical confirmation of nerve proximity is integrated into clinical practice.

Guidance technology further stratifies clinical workflows and device compatibility. Blind techniques continue to persist in certain resource-constrained environments, but nerve stimulator-guided approaches offer incremental confidence through motor response confirmation. Ultrasound guidance, by contrast, has redefined standards of practice in many centers by providing direct visualization of anatomy, which improves block accuracy and reduces reliance on secondary localization methods. As a result, device features that facilitate ultrasound visualization, such as echogenic catheter design and compatible insertion kits, resonate strongly with teams prioritizing image-guided regional anesthesia.

End-user environments also affect procurement and utilization patterns. Ambulatory surgical centers prioritize rapid turnover, minimal opioid-related complications, and devices that streamline same-day discharge. Hospitals often balance a broader case mix and invest in clinician training and multidisciplinary pathways that support continuous catheter programs across orthopedic and obstetric services. Specialty clinics concentrate on procedure-specific workflows and may adopt devices that align with focused clinical protocols and patient throughput demands.

Applications provide a final lens through which clinicians assess catheter solutions. Obstetric analgesia requires devices and protocols suited for both cesarean delivery and labor pain management, with emphasis on maternal mobility and neonatal safety. Orthopedic surgery presents diverse needs across hip, knee, and shoulder procedures, with pain control strategies that facilitate early mobilization and rehabilitation. Postoperative pain management beyond the operating theater demands secure catheter fixation, infection prevention measures, and clear outpatient protocols to support home-based analgesia when indicated. Taken together, these segmentation perspectives reveal why device portfolios and go-to-market approaches must align tightly with clinical workflows and setting-specific priorities.

A nuanced regional perspective illustrating how infrastructure, reimbursement, and practice variation across the Americas, EMEA, and Asia-Pacific influence device adoption and commercialization strategies

Regional dynamics exert a powerful influence on device selection, clinical training models, and distribution strategies, shaped by differences in healthcare infrastructure, reimbursement practices, and clinical practice patterns. In the Americas, clinical emphasis on enhanced recovery, orthopedic volume, and obstetric services drives interest in devices that support accelerated rehabilitation and strong safety profiles. Urban tertiary centers emphasize advanced imaging integration and multidisciplinary pathways, while ambulatory sites prioritize devices that minimize procedure time and support same-day discharge.

Across Europe, the Middle East, and Africa, heterogeneity in healthcare systems creates diverse adoption environments. High-resource hospitals in Western Europe typically adopt ultrasound-guided regional anesthesia widely, investing in simulation-based clinician training and standardized protocols. Meanwhile, in some parts of the Middle East and Africa, variability in access to imaging equipment and trained personnel leads to continued use of alternative guidance strategies and greater sensitivity to device cost and durability. Distribution networks and regulatory pathways also differ across this broad region, influencing how manufacturers structure market entry and support services.

In the Asia-Pacific region, rapid growth of surgical volumes and expanding ambulatory care capacity drive demand for solutions that can scale across high-throughput settings. Training programs and partnerships with academic centers accelerate adoption of image-guided techniques in many markets, while localized manufacturing and supply arrangements often influence procurement decisions. Across these regions, stakeholders respond to both global clinical trends and region-specific constraints, prompting manufacturers to tailor commercial models, educational outreach, and service offerings to local needs while maintaining consistent device performance standards.

A strategic evaluation of how product innovation, clinician education, and service models converge to define competitive advantage and influence procurement choices in regional anesthesia

Competitive dynamics in the continuous peripheral nerve block catheter space center on product innovation, clinical support services, and the ability to demonstrate consistent performance in real-world settings. Leading manufacturers differentiate through catheter materials and fixation systems designed to reduce dislodgement and infection risk, as well as through accessory kits that simplify sterile technique and ultrasound integration. Equally important are training programs, simulation tools, and clinical partnerships that accelerate adoption by improving clinician confidence and procedural consistency.

Distribution and service models also underpin competitive positioning. Firms that offer bundled solutions combining devices, clinician education, and post-market surveillance gain traction with hospital systems seeking predictable outcomes and reduced operational burden. Strategic collaborations with imaging equipment providers, anesthesiology societies, and academic centers amplify visibility and support guideline-aligned practice adoption. Vendors that maintain responsive supply chains and localized technical support tend to perform better in markets where hospitals prioritize service continuity and rapid device replenishment.

Finally, companies that invest in evidence generation through registries, observational studies, and pragmatic clinical collaborations help to validate real-world effectiveness and inform best practices. This clinical evidence, when paired with robust training and service ecosystems, reinforces trust among clinician champions and purchasing committees, creating a durable competitive advantage that extends beyond product specifications alone.

Actionable recommendations for manufacturers and healthcare leaders to align product development, clinician training, and supply strategies with real-world clinical and operational priorities

Industry leaders can act decisively to capture clinical and commercial opportunities by aligning R&D priorities with end-user workflows and by strengthening clinical support capabilities. Prioritizing catheter features that enhance ultrasound visualization, secure fixation, and infection control will address the practical pain points most commonly cited by clinicians. In parallel, investing in scalable training programs and simulation tools will reduce variability in technique and accelerate adoption, particularly in hospitals and ambulatory centers seeking operator consistency.

Operationally, manufacturers should consider supply chain strategies that reduce exposure to tariff variability and improve responsiveness to regional demand fluctuations. Options include selectively nearshoring high-volume production, developing modular packaging to mitigate tariff thresholds, and formalizing service-level agreements that assure timely replenishment. Commercial teams should emphasize bundled offerings that link device procurement with clinician education, warranty support, and data collection options to quantify procedural outcomes and patient experience.

From a market engagement perspective, leaders should cultivate partnerships with orthopedic and obstetric clinical champions to generate real-world evidence and disseminate best-practice protocols. Tailored value propositions for ambulatory surgical centers, hospitals, and specialty clinics will help address setting-specific priorities such as throughput, rehabilitation timelines, and outpatient catheter management. By integrating clinical, operational, and commercial initiatives, industry players can create compelling, differentiated offerings that support sustainable adoption across diverse care settings.

A transparent research methodology describing how primary clinician interviews, clinical guidance synthesis, and comparative product analysis were integrated to produce actionable insights

This research synthesizes peer-reviewed clinical literature, procedural guidelines, and primary qualitative interviews with anesthesiologists, perioperative nurses, and procurement specialists to develop a comprehensive understanding of device adoption drivers and barriers. The methodology emphasizes triangulation between clinical practice insights, product feature evaluations, and distribution channel analysis to ensure that conclusions reflect both evidence-based medicine and day-to-day operational realities.

Primary data collection included structured interviews and thematic analysis designed to capture clinician preferences around catheter type, guidance technology, and outpatient management. Secondary sources included recent procedural guidelines and device safety communications that inform best practices for infection prevention and catheter fixation. Throughout the process, attention focused on capturing heterogeneity across ambulatory centers, hospitals, and specialty clinics to ensure findings remain applicable across the primary end-user environments.

Analytical methods combined qualitative synthesis with comparative feature mapping across device portfolios and regional market dynamics. Supply chain and policy impacts were assessed through scenario analysis that considered common procurement responses and manufacturer mitigations. The resulting approach prioritizes actionable insight over abstract modeling, delivering recommendations that operational and clinical leaders can implement to optimize adoption and patient outcomes.

A concise and forward-looking conclusion that synthesizes clinical priorities, operational realities, and collaborative strategies underpinning effective adoption of continuous peripheral nerve block catheters

In conclusion, continuous peripheral nerve block catheters occupy a pivotal role in contemporary pain management strategies, with adoption shaped by a confluence of clinical imperatives, imaging technology advances, and evolving care delivery models. Device characteristics that support ultrasound integration, secure fixation, and outpatient management consistently align with stakeholder priorities across ambulatory surgical centers, hospitals, and specialty clinics. Meanwhile, ongoing investments in clinician training and evidence generation remain central to sustaining adoption and improving procedural consistency.

Operational forces, including supply chain resilience and policy shifts, require coordinated responses from manufacturers and procurement teams to preserve access and maintain value-based care objectives. Manufacturers that couple product innovation with robust training, service support, and adaptive supply strategies will be best positioned to meet the complex needs of diverse healthcare settings. Ultimately, sustained collaboration between clinical leaders, industry partners, and institutional purchasers will determine how effectively continuous peripheral nerve block catheters enhance patient recovery while advancing quality and efficiency objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Continuous Peripheral Nerve Block Catheter Market, by Type

  • 8.1. Non Stimulating Catheter
  • 8.2. Stimulating Catheter

9. Continuous Peripheral Nerve Block Catheter Market, by Guidance Technology

  • 9.1. Blind Technique
  • 9.2. Nerve Stimulator Guided
  • 9.3. Ultrasound Guided

10. Continuous Peripheral Nerve Block Catheter Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Continuous Peripheral Nerve Block Catheter Market, by Application

  • 11.1. Obstetric Analgesia
    • 11.1.1. C Section
    • 11.1.2. Labor Pain Management
  • 11.2. Orthopedic Surgery
    • 11.2.1. Hip Replacement
    • 11.2.2. Knee Replacement
    • 11.2.3. Shoulder Surgery
  • 11.3. Postoperative Pain Management

12. Continuous Peripheral Nerve Block Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Continuous Peripheral Nerve Block Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Continuous Peripheral Nerve Block Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Continuous Peripheral Nerve Block Catheter Market

16. China Continuous Peripheral Nerve Block Catheter Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Avanos Medical, Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. Dyna Medical Corporation
  • 17.8. Epimed International Inc.
  • 17.9. ICU Medical, Inc.
  • 17.10. Lepu Medical Technology (Beijing) Co., Ltd.
  • 17.11. Medline Industries, LP
  • 17.12. Medtronic plc
  • 17.13. Merit Medical Systems, Inc.
  • 17.14. Nipro Corporation
  • 17.15. Owens & Minor, Inc.
  • 17.16. PAJUNK GmbH Medizintechnologie
  • 17.17. Poly Medicure Ltd.
  • 17.18. Shunmei
  • 17.19. Teleflex Incorporated
  • 17.20. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 121. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 142. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 149. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)